Lamotrigine Related Published Studies
Well-designed clinical trials related to Lamotrigine
Analysis of three lamotrigine extended-release clinical trials: comparison of
pragmatic ITT and LOCF methodologies. [2012]
Longitudinal changes in magnetisation transfer ratio in secondary progressive
multiple sclerosis: data from a randomised placebo controlled trial of
lamotrigine. [2012]
Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial. [2011.10]
A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression. [2011.10]
Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers. [2011.07]
Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. [2011.02]
Pregabalin effect on steady-state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. [2011.02]
Lamotrigine in the immediate treatment of outpatients with depersonalization disorder without psychiatric comorbidity: randomized, double-blind, placebo-controlled study. [2011.02]
Cognitive and behavioral effects of lamotrigine and carbamazepine monotherapy in patients with newly diagnosed or untreated partial epilepsy. [2011.01]
Lamotrigine in the immediate treatment of outpatients with depersonalization
disorder without psychiatric comorbidity: randomized, double-blind,
placebo-controlled study. [2011]
Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study. [2010.11]
Effects of lamotrigine on hippocampal activation in corticosteroid-treated patients. [2010.11]
A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures. [2010.09]
Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine. [2010.09]
A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. [2010.08]
Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). [2010.08]
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. [2010.07]
A fMRI evaluation of lamotrigine for the treatment of trigeminal neuropathic pain: pilot study. [2010.06]
Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression. [2010.05]
Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity. [2010.04]
Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease. [2010.04]
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. [2010.03.04]
Antiepileptic drugs and quality of life in the elderly: results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age. [2010.03]
Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine. [2010]
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a
randomised, double-blind, placebo-controlled, parallel-group trial. [2010]
Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures
and Alzheimer's disease. [2010]
The effect of raltegravir on the glucuronidation of lamotrigine. [2009.10]
A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. [2009.09]
Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine. [2009.08]
[Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children] [2009.08]
Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. [2009.07]
Attenuation of amygdala atrophy with lamotrigine in patients receiving corticosteroid therapy. [2009.06]
A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive. [2009.06]
Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial. [2009.05]
Lamotrigine and valproate pharmacokinetics interactions in epileptic patients. [2009.04]
Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: a prospective randomized study. [2009.04]
Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. [2009.04]
The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis. [2009.04]
Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. [2009.03]
Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. [2009.02]
A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. [2008.12]
Bioequivalence of generic lamotrigine 100-mg tablets in healthy Thai male volunteers: a randomized, single-dose, two-period, two-sequence crossover study. [2008.10]
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects. [2008.09]
Attenuation of the effects of corticosteroids on declarative memory with lamotrigine. [2008.09]
Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine. [2008.08]
Long-term tolerability and efficacy of lamotrigine in infants 1 to 24 months old. [2008.08]
Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. [2008.06.15]
Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months. [2008.05.27]
Population pharmacokinetics of lamotrigine in elderly patients. [2008.04]
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study. [2008.04]
Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. [2008.03]
[A retrospective study of the effectiveness of lamotrigine in monotherapy for the treatment of epileptic seizures. The ERELMO study] [2008.02.16]
Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view. [2008.02]
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. [2008.01.01]
Open-label, concomitant use of lamotrigine and other medications for bipolar disorder. [2008.01]
Efficacy and safety of antidepressant augmentation with lamotrigine in patients with treatment-resistant depression: a randomized, placebo-controlled, double-blind study. [2008]
Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. [2007.12]
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. [2007.11]
Lamotrigine extended-release as adjunctive therapy for partial seizures. [2007.10.16]
Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. [2007.10]
A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis. [2007.09]
Monotherapy of lamotrigine versus carbamazepine in patients with poststroke seizure. [2007.07]
An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. [2007.07]
Sodium valproate versus lamotrigine: A randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy. [2007.07]
The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double-blind, placebo-controlled study. [2007.07]
Effectiveness and weight effects of open-label lamotrigine with and without concomitant psychotropic medications in patients with bipolar I disorder. [2007.05.22]
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. [2007.05]
Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study. [2007.05]
Well-designed clinical trials possibly related to Lamotrigine
Pharmacotherapy to control behavioral symptoms in children with autism. [2012]
Polarity index of pharmacological agents used for maintenance treatment of
bipolar disorder. [2012]
Pharmacological augmentation strategies for schizophrenia patients with
insufficient response to clozapine: a quantitative literature review. [2012]
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial. [2011.10]
Rufinamide for the treatment of Lennox-Gastaut syndrome. [2011.04]
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression. [2011.04]
Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review. [2011.03.21]
Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder. [2011.02]
Pharmacotherapy of borderline personality disorder: a systematic review for
publication purpose. [2011]
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of
depression in patients with bipolar I disorder: a randomized, double-blind,
placebo-controlled trial. [2011]
Rufinamide for the treatment of Lennox-Gastaut syndrome. [2011]
Treatment options for bipolar depression: a systematic review of randomized, controlled trials. [2010.10]
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. [2010.10]
Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex. [2010.10]
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. [2010.02]
Effects of antiepileptic drugs on associative LTP-like plasticity in human motor
cortex. [2010]
The influence of drug-drug interaction and patients' characteristics on valproic acid's clearance in adults with epilepsy using nonlinear mixed effects modeling. [2009.12.08]
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. [2009.03.17]
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. [2009.03]
Subjective perception of cognition is related to mood and not performance. [2009.03]
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. [2008.02]
STEP-BD and bipolar depression: what have we learned? [2007.12]
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. [2007.10]
Management of neuropathic pain. [2007.08]
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. [2007.07]
Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients. [2007.07]
The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. [2007.06]
Other research related to Lamotrigine
Early antidepressant effect of memantine during augmentation of lamotrigine
inadequate response in bipolar depression: a double-blind, randomized,
placebo-controlled trial. [2012]
Lamotrigine in the treatment of unipolar depression with and without
comorbidities: a literature review. [2012]
Lamotrigine XR Conversion to Monotherapy: First Study Using a Historical Control Group. [2011.12.03]
Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: A nested, case-control study. [2011.11.29]
Using interleaved transcranial magnetic stimulation/functional magnetic resonance
imaging (fMRI) and dynamic causal modeling to understand the discrete circuit
specific changes of medications: lamotrigine and valproic acid changes in motor
or prefrontal effective connectivity. [2011]
Carbamazepine for acute and chronic pain in adults. [2011]
|
